Le Lézard
Classified in: Ebola virus

Global Animal Pharmaceuticals (Drugs, Vaccine, Medicated Feed) Market, Forecast & Opportunities, 2026 - ResearchAndMarkets.com


The "Global Animal Pharmaceuticals Market, By Product Type (Drugs, Vaccine, Medicated Feed), By Animal Type, By Route of Administration, By Type of Infection, By End User, By Distribution Channel, By Region, By Company, Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.

The animal pharmaceuticals market was valued USD45.23 billion in 2020 and is likely to grow with a steady CAGR of 7.05% in the forecast period to reach USD68.45 billion by 2026 due to the increase in pet adoption, rise in overall consumption of milk and meat, and fatal diseases like Ebola and swine flu spreading from animals.

Animal pharmaceuticals are highly beneficial in the diagnosis and treatment of animal disorders. The emergence of new economies has led more governments and pharma companies to fund animal healthcare, consequently pushing the market forward. The restraining factors for the market can be the government rules regarding animal testing, and the probability of the sales of fake medicines across e-commerce platforms.

The Global Animal Pharmaceuticals market is segmented based on product type, animal type, route of administration, type of infection, end-user, distribution channel and region. Based on product type, the market is segmented into drugs, vaccines and medicated feed. The drugs segment dominates the market due to the rise in diseases and various infections. On the basis of animal type, the market is segmented into companion and livestock animals.

Companion animals tend to hold a larger share in the market as pet owners ensure their pet's health and well-being. As compared to livestock animals, companion animals receive special care and veterinary treatment from their owners, which is the major factor driving the market share of this segment.

Based on route of administration, the pharmaceutical products, i.e., drugs and medicated feed are given orally hence the oral route of administration dominates the market. Viral infections dominate the type of infection segment pertaining to their ease of spread and rate of infection.

Veterinary clinics are expected to grow at a faster rate because they provide specialized pet/ livestock treatment however, veterinary hospitals are still likely to dominate the end-user segment. Based on distribution channel, e-commerce segment is expected to grow at a faster rate in the future because of continuous technological advancements that make it the most convenient option for pet and livestock owners.

The overall animal pharmaceuticals market is widespread, expanding itself to various regions including Asia-Pacific, Europe, North America, South America, and Middle East & Africa. North America has the largest market share by virtue of the pre-existing established pharmaceutical companies and the increasing consumption of meat and milk in the region. However, the fastest growth is shown by the Asia-Pacific region due to the prevalence of animal-borne diseases like swine flu and Ebola.

The inter-company competition keeps on increasing parallelly with the market which in turn leads to innovations in technology, thus enhancing the animal healthcare sector.

The top leading players of the animal pharmaceuticals market are

Years considered for this report:

Key Target Audience:

Report Scope:

Global Animal Pharmaceuticals Market, By Product Type:

Global Animal Pharmaceuticals Market, By Animal Type:

Global Animal Pharmaceuticals Market, By Route of Administration:

Global Animal Pharmaceuticals Market, By Type of Infection:

Global Animal Pharmaceuticals Market, By End-User:

Global Animal Pharmaceuticals Market, By Distribution Channel:

Global Animal Pharmaceuticals Market, By Region:

For more information about this report visit https://www.researchandmarkets.com/r/cyvwz7

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: